Cargando…

Integrating metabolomic data with machine learning approach for discovery of Q-markers from Jinqi Jiangtang preparation against type 2 diabetes

BACKGROUND: Jinqi Jiangtang (JQJT) has been widely used in clinical practice to prevent and treat type 2 diabetes. However, little research has been done to identify and classify its quality markers (Q-markers) associated with anti-diabetes bioactivity. In this study, a strategy combining mass spect...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lele, Xue, Yan, Wei, Jinchao, Dai, Qi, Li, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980607/
https://www.ncbi.nlm.nih.gov/pubmed/33741031
http://dx.doi.org/10.1186/s13020-021-00438-x
_version_ 1783667462133252096
author Yang, Lele
Xue, Yan
Wei, Jinchao
Dai, Qi
Li, Peng
author_facet Yang, Lele
Xue, Yan
Wei, Jinchao
Dai, Qi
Li, Peng
author_sort Yang, Lele
collection PubMed
description BACKGROUND: Jinqi Jiangtang (JQJT) has been widely used in clinical practice to prevent and treat type 2 diabetes. However, little research has been done to identify and classify its quality markers (Q-markers) associated with anti-diabetes bioactivity. In this study, a strategy combining mass spectrometry-based untargeted metabolomics with backpropagation artificial neural network (BP-ANN)-based machine learning approach was proposed to screen Q-markers from JQJT preparation. METHODS: This strategy mainly involved chemical profiling of herbal medicines, statistic processing of metabolomic datasets, detection of different anti-diabetes activities and establishment of BP-ANN model. The chemical features of seventy-eight batches of JQJT extracts were first profiled by using the untargeted UPLC-LTQ-Orbitrap metabolomic approach. The chemical features obtained which were associated with different anti-diabetes activities based on three modes of action were normalized, ranked, and then pre-selected by using ReliefF feature selection. BP-ANN model was then established and optimized to screen Q-markers based on mean impact value (MIV). RESULTS: Optimized BP-ANN architecture was established with high accuracy of R > 0.9983 and relative low error of MSE < 0.0014, which showed better performance than that of partial least square (PLS) model (R(2) < 0.5). Meanwhile, the BP-ANN model was subsequently applied to further screen potential bioactive components from the pre-selected chemical features by calculating their MIVs. With this machine learning model, 10 potential Q-markers with bioactivity were discovered from JQJT. The tested anti-diabetes bioactivities of 78 batches of JQJT could be accurately predicted. CONCLUSIONS: This proposed artificial intelligence approach is desirable for quick and easy identification of Q-markers with bioactivity from JQJT preparation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13020-021-00438-x.
format Online
Article
Text
id pubmed-7980607
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79806072021-03-22 Integrating metabolomic data with machine learning approach for discovery of Q-markers from Jinqi Jiangtang preparation against type 2 diabetes Yang, Lele Xue, Yan Wei, Jinchao Dai, Qi Li, Peng Chin Med Research BACKGROUND: Jinqi Jiangtang (JQJT) has been widely used in clinical practice to prevent and treat type 2 diabetes. However, little research has been done to identify and classify its quality markers (Q-markers) associated with anti-diabetes bioactivity. In this study, a strategy combining mass spectrometry-based untargeted metabolomics with backpropagation artificial neural network (BP-ANN)-based machine learning approach was proposed to screen Q-markers from JQJT preparation. METHODS: This strategy mainly involved chemical profiling of herbal medicines, statistic processing of metabolomic datasets, detection of different anti-diabetes activities and establishment of BP-ANN model. The chemical features of seventy-eight batches of JQJT extracts were first profiled by using the untargeted UPLC-LTQ-Orbitrap metabolomic approach. The chemical features obtained which were associated with different anti-diabetes activities based on three modes of action were normalized, ranked, and then pre-selected by using ReliefF feature selection. BP-ANN model was then established and optimized to screen Q-markers based on mean impact value (MIV). RESULTS: Optimized BP-ANN architecture was established with high accuracy of R > 0.9983 and relative low error of MSE < 0.0014, which showed better performance than that of partial least square (PLS) model (R(2) < 0.5). Meanwhile, the BP-ANN model was subsequently applied to further screen potential bioactive components from the pre-selected chemical features by calculating their MIVs. With this machine learning model, 10 potential Q-markers with bioactivity were discovered from JQJT. The tested anti-diabetes bioactivities of 78 batches of JQJT could be accurately predicted. CONCLUSIONS: This proposed artificial intelligence approach is desirable for quick and easy identification of Q-markers with bioactivity from JQJT preparation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13020-021-00438-x. BioMed Central 2021-03-19 /pmc/articles/PMC7980607/ /pubmed/33741031 http://dx.doi.org/10.1186/s13020-021-00438-x Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yang, Lele
Xue, Yan
Wei, Jinchao
Dai, Qi
Li, Peng
Integrating metabolomic data with machine learning approach for discovery of Q-markers from Jinqi Jiangtang preparation against type 2 diabetes
title Integrating metabolomic data with machine learning approach for discovery of Q-markers from Jinqi Jiangtang preparation against type 2 diabetes
title_full Integrating metabolomic data with machine learning approach for discovery of Q-markers from Jinqi Jiangtang preparation against type 2 diabetes
title_fullStr Integrating metabolomic data with machine learning approach for discovery of Q-markers from Jinqi Jiangtang preparation against type 2 diabetes
title_full_unstemmed Integrating metabolomic data with machine learning approach for discovery of Q-markers from Jinqi Jiangtang preparation against type 2 diabetes
title_short Integrating metabolomic data with machine learning approach for discovery of Q-markers from Jinqi Jiangtang preparation against type 2 diabetes
title_sort integrating metabolomic data with machine learning approach for discovery of q-markers from jinqi jiangtang preparation against type 2 diabetes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980607/
https://www.ncbi.nlm.nih.gov/pubmed/33741031
http://dx.doi.org/10.1186/s13020-021-00438-x
work_keys_str_mv AT yanglele integratingmetabolomicdatawithmachinelearningapproachfordiscoveryofqmarkersfromjinqijiangtangpreparationagainsttype2diabetes
AT xueyan integratingmetabolomicdatawithmachinelearningapproachfordiscoveryofqmarkersfromjinqijiangtangpreparationagainsttype2diabetes
AT weijinchao integratingmetabolomicdatawithmachinelearningapproachfordiscoveryofqmarkersfromjinqijiangtangpreparationagainsttype2diabetes
AT daiqi integratingmetabolomicdatawithmachinelearningapproachfordiscoveryofqmarkersfromjinqijiangtangpreparationagainsttype2diabetes
AT lipeng integratingmetabolomicdatawithmachinelearningapproachfordiscoveryofqmarkersfromjinqijiangtangpreparationagainsttype2diabetes